A DRUG that women use as a contraceptive alternative has had its product information expanded by the TGA to include precautions and risks relating to blood clots.
Bayer's Diane-35 ED, also used to treat acne, now comes with more explicit product labelling that warns of the elevated risks of arterial thromboembolisms such as strokes and heart attacks, as well as hereditary predispositions that increase the risk of clots.
The move follows pressure from Federal Labor MP Julian Hill who wants the drug either banned or heavily restricted following his daughter's bout with a blood clot after taking the drug.
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Jan 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Jan 18
